| abstract |
New quinazolinyl-amino derivatives useful as <alpha>1-adr-eno-receptors blockers are described. The secom-pou-nds can be used as therapeutical agents for treating affections and diseases related with the hyperactivity of the <alpha>-adrenergic system, as, for example, arterial hypertension, prostate benign hyperplasia (BHP), high intraocular pressure and hypercholesterolemia. Processes for the preparation of the above said compounds anre also described. |